Edward Tenthoff
Stock Analyst at Piper Sandler
(3.03)
# 2,305
Out of 4,376 analysts
1243
Total ratings
37.2%
Success rate
1.8%
Average return
Main Sectors:
Stocks Rated by Edward Tenthoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FATE Fate Therapeutics | Reiterated: Buy | $6 | $1.98 | +203.03% | 36 | Jun 5, 2026 | |
| ARVN Arvinas | Reiterated: Buy | $20 | $7.42 | +169.54% | 32 | Jun 3, 2026 | |
| FULC Fulcrum Therapeutics | Downgraded: Sell | $23 → $3 | $3.69 | -18.70% | 20 | Jun 2, 2026 | |
| IBRX ImmunityBio | Reiterated: Buy | $12 | $6.92 | +73.41% | 7 | Jun 1, 2026 | |
| INO Inovio Pharmaceuticals | Reiterated: Buy | $6 | $1.07 | +460.75% | 7 | May 22, 2026 | |
| CRDF Cardiff Oncology | Reiterated: Buy | $6 | $1.50 | +300.00% | 6 | May 15, 2026 | |
| CAMP Camp4 Therapeutics | Reiterated: Buy | $12 | $4.11 | +191.97% | 13 | May 15, 2026 | |
| MIST Milestone Pharmaceuticals | Reiterated: Buy | $4 → $7 | $1.23 | +469.11% | 19 | May 14, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $48 → $45 | $17.04 | +164.08% | 24 | May 14, 2026 | |
| IPSC Century Therapeutics | Reiterated: Buy | $4 | $2.13 | +87.79% | 20 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $26.71 | +117.15% | 14 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $78 → $64 | $32.62 | +96.20% | 22 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $13 → $6 | $0.7332 | +718.33% | 16 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $7 | $1.27 | +451.18% | 4 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $73.09 | +50.50% | 72 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $33 | $11.77 | +180.37% | 46 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.00 | +300.00% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $69 | $47.44 | +45.45% | 109 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $16.37 | +126.02% | 18 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $12.87 | +86.48% | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $51.84 | +112.19% | 65 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $489 | $303.05 | +61.36% | 100 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 → $16 | $9.08 | +76.21% | 8 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $13.95 | +150.90% | 15 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.43 | +459.44% | 5 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.44 | +108.33% | 28 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $6.63 | +201.66% | 14 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 → $125 | $74.13 | +68.62% | 21 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $26.09 | -23.34% | 28 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $2.95 | +408.47% | 24 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $2 | $29.46 | n/a | 13 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $1.27 | n/a | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $3.83 | n/a | 14 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.0004 | n/a | 20 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6.93 → $207.78 | $2.20 | n/a | 10 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $4.19 | n/a | 14 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $13 | $0.47 | n/a | 10 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $0.3 | $0.000001 | n/a | 6 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1 → $38 | $73.65 | n/a | 8 | Oct 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $44 | $16.86 | n/a | 3 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $13 | $4.72 | n/a | 14 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 → $60 | $6.20 | n/a | 15 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $323 | $446.83 | n/a | 49 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $9 | $0.69 | n/a | 9 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $40 | $71.48 | n/a | 17 | Aug 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $52.70 | n/a | 34 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $309 → $250 | $891.32 | n/a | 21 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €266.02 | $729.53 | n/a | 1 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $1.5 | $0.789 | n/a | 2 | Jun 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $2.5 | $1.42 | n/a | 5 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $70 → $90 | $129.16 | n/a | 3 | Mar 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.000001 | n/a | 4 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5 → $60 | $3.17 | n/a | 6 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $208 | $15.75 | n/a | 44 | Jun 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $10.30 | n/a | 1 | Jun 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $90 → $5 | $9.49 | n/a | 23 | Feb 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $0.000001 | n/a | 1 | Dec 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $19 | $36.30 | n/a | 5 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $1.03 | n/a | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4 → $0.1 | $0.001 | n/a | 8 | Mar 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $5 | $0.0001 | n/a | 9 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $557 | $635.45 | n/a | 35 | Sep 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $4 | $1.20 | n/a | 6 | Feb 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $5.09 | n/a | 5 | Sep 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $79.42 | n/a | 1 | Aug 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $42.09 | n/a | 6 | Mar 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1 | $0.000001 | n/a | 1 | Jul 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $20 | $74.48 | n/a | 1 | Jul 23, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $0.8362 | n/a | 1 | Mar 4, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $0.4733 | n/a | 1 | Feb 20, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $2.5 | $8.23 | n/a | 1 | Dec 31, 2012 |
Fate Therapeutics
Jun 5, 2026
Reiterated: Buy
Price Target: $6
Current: $1.98
Upside: +203.03%
Arvinas
Jun 3, 2026
Reiterated: Buy
Price Target: $20
Current: $7.42
Upside: +169.54%
Fulcrum Therapeutics
Jun 2, 2026
Downgraded: Sell
Price Target: $23 → $3
Current: $3.69
Upside: -18.70%
ImmunityBio
Jun 1, 2026
Reiterated: Buy
Price Target: $12
Current: $6.92
Upside: +73.41%
Inovio Pharmaceuticals
May 22, 2026
Reiterated: Buy
Price Target: $6
Current: $1.07
Upside: +460.75%
Cardiff Oncology
May 15, 2026
Reiterated: Buy
Price Target: $6
Current: $1.50
Upside: +300.00%
Camp4 Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $12
Current: $4.11
Upside: +191.97%
Milestone Pharmaceuticals
May 14, 2026
Reiterated: Buy
Price Target: $4 → $7
Current: $1.23
Upside: +469.11%
Dyne Therapeutics
May 14, 2026
Reiterated: Buy
Price Target: $48 → $45
Current: $17.04
Upside: +164.08%
Century Therapeutics
May 14, 2026
Reiterated: Buy
Price Target: $4
Current: $2.13
Upside: +87.79%
May 13, 2026
Reiterated: Buy
Price Target: $58
Current: $26.71
Upside: +117.15%
May 13, 2026
Reiterated: Buy
Price Target: $78 → $64
Current: $32.62
Upside: +96.20%
May 12, 2026
Rated: Buy
Price Target: $13 → $6
Current: $0.7332
Upside: +718.33%
May 12, 2026
Reiterated: Buy
Price Target: $6 → $7
Current: $1.27
Upside: +451.18%
May 8, 2026
Reiterated: Buy
Price Target: $110
Current: $73.09
Upside: +50.50%
May 8, 2026
Reiterated: Buy
Price Target: $30 → $33
Current: $11.77
Upside: +180.37%
May 8, 2026
Reiterated: Buy
Price Target: $12
Current: $3.00
Upside: +300.00%
May 8, 2026
Reiterated: Buy
Price Target: $69
Current: $47.44
Upside: +45.45%
May 8, 2026
Reiterated: Buy
Price Target: $37
Current: $16.37
Upside: +126.02%
May 8, 2026
Reiterated: Buy
Price Target: $24
Current: $12.87
Upside: +86.48%
May 5, 2026
Reiterated: Buy
Price Target: $110
Current: $51.84
Upside: +112.19%
May 1, 2026
Reiterated: Buy
Price Target: $489
Current: $303.05
Upside: +61.36%
Apr 27, 2026
Rated: Buy
Price Target: $8 → $16
Current: $9.08
Upside: +76.21%
Apr 10, 2026
Reiterated: Buy
Price Target: $35
Current: $13.95
Upside: +150.90%
Mar 2, 2026
Reiterated: Buy
Price Target: $8
Current: $1.43
Upside: +459.44%
Feb 27, 2026
Reiterated: Buy
Price Target: $3
Current: $1.44
Upside: +108.33%
Feb 13, 2026
Maintained: Hold
Price Target: $20
Current: $6.63
Upside: +201.66%
Dec 9, 2025
Reiterated: Buy
Price Target: $98 → $125
Current: $74.13
Upside: +68.62%
Dec 4, 2025
Reiterated: Buy
Price Target: $20
Current: $26.09
Upside: -23.34%
Nov 24, 2025
Reiterated: Buy
Price Target: $15
Current: $2.95
Upside: +408.47%
Apr 1, 2025
Reiterated: Buy
Price Target: $3 → $2
Current: $29.46
Upside: n/a
Mar 28, 2025
Reiterated: Buy
Price Target: $65
Current: $1.27
Upside: n/a
Feb 7, 2025
Reiterated: Buy
Price Target: $60
Current: $3.83
Upside: n/a
Oct 23, 2024
Reiterated: Buy
Price Target: $5
Current: $0.0004
Upside: n/a
Apr 3, 2024
Maintained: Buy
Price Target: $6.93 → $207.78
Current: $2.20
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $52
Current: $4.19
Upside: n/a
Apr 11, 2023
Maintained: Buy
Price Target: $9 → $13
Current: $0.47
Upside: n/a
Feb 23, 2023
Downgraded: Hold
Price Target: $3 → $0.3
Current: $0.000001
Upside: n/a
Oct 27, 2022
Upgraded: Buy
Price Target: $1 → $38
Current: $73.65
Upside: n/a
Aug 25, 2022
Maintained: Buy
Price Target: $37 → $44
Current: $16.86
Upside: n/a
Aug 12, 2022
Maintained: Buy
Price Target: $20 → $13
Current: $4.72
Upside: n/a
May 23, 2022
Maintained: Buy
Price Target: $160 → $60
Current: $6.20
Upside: n/a
Oct 18, 2021
Maintained: Buy
Price Target: $323
Current: $446.83
Upside: n/a
Sep 20, 2021
Maintained: Buy
Price Target: $7 → $9
Current: $0.69
Upside: n/a
Aug 8, 2021
Maintained: Buy
Price Target: $42 → $40
Current: $71.48
Upside: n/a
Jun 28, 2021
Maintained: Buy
Price Target: $36
Current: $52.70
Upside: n/a
Jun 7, 2021
Maintained: Hold
Price Target: $309 → $250
Current: $891.32
Upside: n/a
Feb 4, 2021
Maintained: Hold
Price Target: €266.02
Current: $729.53
Upside: n/a
Jun 30, 2020
Reiterated: Buy
Price Target: $3 → $1.5
Current: $0.789
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: $5 → $2.5
Current: $1.42
Upside: n/a
Mar 20, 2020
Upgraded: Buy
Price Target: $70 → $90
Current: $129.16
Upside: n/a
Dec 11, 2019
Maintained: Buy
Price Target: $10
Current: $0.000001
Upside: n/a
Sep 5, 2019
Rated: Hold
Price Target: $5 → $60
Current: $3.17
Upside: n/a
Jun 21, 2019
Reiterated: Buy
Price Target: $200 → $208
Current: $15.75
Upside: n/a
Jun 4, 2019
Reiterated: Buy
Price Target: $32
Current: $10.30
Upside: n/a
Feb 28, 2019
Downgraded: Sell
Price Target: $90 → $5
Current: $9.49
Upside: n/a
Dec 12, 2018
Reiterated: Buy
Price Target: $30
Current: $0.000001
Upside: n/a
Nov 6, 2018
Maintained: Buy
Price Target: $16 → $19
Current: $36.30
Upside: n/a
Oct 22, 2018
Initiated Coverage: Buy
Price Target: $23
Current: $1.03
Upside: n/a
Mar 12, 2018
Downgraded: Sell
Price Target: $4 → $0.1
Current: $0.001
Upside: n/a
Nov 2, 2017
Maintained: Buy
Price Target: $17 → $5
Current: $0.0001
Upside: n/a
Sep 11, 2017
Reiterated: Buy
Price Target: $557
Current: $635.45
Upside: n/a
Feb 9, 2017
Reiterated: Buy
Price Target: $5 → $4
Current: $1.20
Upside: n/a
Sep 7, 2016
Reiterated: Buy
Price Target: $1
Current: $5.09
Upside: n/a
Aug 18, 2016
Reiterated: Buy
Price Target: $35
Current: $79.42
Upside: n/a
Mar 10, 2016
Maintained: Hold
Price Target: n/a
Current: $42.09
Upside: n/a
Jul 9, 2015
Downgraded: Hold
Price Target: $1
Current: $0.000001
Upside: n/a
Jul 23, 2013
Downgraded: Sell
Price Target: $20
Current: $74.48
Upside: n/a
Mar 4, 2013
Rated: Buy
Price Target: $6
Current: $0.8362
Upside: n/a
Feb 20, 2013
Maintained: Buy
Price Target: $6
Current: $0.4733
Upside: n/a
Dec 31, 2012
Rated: Buy
Price Target: $2.5
Current: $8.23
Upside: n/a